VitroLabs has a total of 31 patents globally, out of which 9 have been granted. Of these 31 patents, more than 87% patents are active. The USA is where VitroLabs has filed the maximum number of patents, followed by Australia. Parallelly, the USA seems to be the main focused R&D centre of VitroLabs and is also the origin country of the firm.
VitroLabs was founded in the year 2016 by Dusko Ilic and Ingvar Helgason. The company develops a platform that manufactures real leather using stem cell-based technologies.
Do read about some of the most popular patents of VitroLabs which have been covered by us in this article and also you can find VitroLabs patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over VitroLabs patent portfolio.
How many patents does VitroLabs have?
VitroLabs has a total of 31 patents globally. These patents belong to 4 unique patent families. Out of 31 patents, 27 patents are active.
How Many Patents did VitroLabs File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | VitroLabs Applications Filed | VitroLabs Patents Granted |
| 2022 | 6 | 2 |
| 2021 | 1 | 2 |
| 2020 | 7 | 1 |
| 2019 | 2 | 1 |
| 2018 | 1 | – |
| 2017 | 12 | – |
| 2016 | – | – |
| 2015 | – | – |
How many VitroLabs patents are Alive/Dead?
Worldwide Patents
How Many Patents did VitroLabs File in Different Countries?
Where are Research Centres of VitroLabs Patents Located?
The R&D Centres of patents filed by VitroLabs is in the USA.
Most Cited VitroLabs Patent
US20190136060A1 is the most popular patent in the VitroLabs portfolio. It has received 16 citations so far from companies like Modern Meadow and Marathon Petroleum Company.
List of VitroLabs Patents
| VitroLabs Patents | Title |
| US11739217B2 | Engineered Skin Equivalent, Method Of Manufacture Thereof And Products Derived Therefrom |
| US11591471B2 | Engineered Skin Equivalent, Method Of Manufacture Thereof And Products Derived Therefrom |
| US11377559B2 | Engineered Skin Equivalent, Method Of Manufacture Thereof And Products Derived Therefrom |
| US11091639B2 | Engineered Skin Equivalent, Method Of Manufacture Thereof And Products Derived Therefrom |
| US10711136B2 | Engineered Skin Equivalent, Method Of Manufacture Thereof And Products Derived Therefrom |
| US10273549B2 | Engineered Skin Equivalent, Method Of Manufacture Thereof And Products Derived Therefrom |
| US20230012452A1 | Scalable Bioreactor Systems And Methods For Tissue Engineering |
| EP4004180A4 | Scalable Bioreactor Systems And Methods For Tissue Engineering |
| EP3445866A4 | Engineered Skin Equivalent, Method Of Manufacture Thereof And Products Derived Therefrom |
| CN116463278A | Engineered Skin Equivalent, Method Of Manufacture And Products Derived Therefrom |
| CN109312381A | Engineered Skin Equivalent, Method Of Manufacture Thereof And Products Derived Therefrom |
| WO2022178441A1 | Immortalized Cell Line For Engineered Synthetic Leather |
| JP2023082100A | Engineered Skin Equivalents, Methods Of Making Them And Products Derived Therefrom |
| CA3021688A1 | Engineered Skin Equivalent, Method Of Manufacture Thereof And Products Derived Therefrom |
| AU2022200445B2 | Engineered Skin Equivalent, Method Of Manufacture Thereof And Products Derived Therefrom |
| AU2017252443B2 | Engineered Skin Equivalent, Method Of Manufacture Thereof And Products Derived Therefrom |
| AU2022222783A1 | Immortalized Cell Line For Engineered Synthetic Leather |
| AU2020322793A1 | Scalable Bioreactor Systems And Methods For Tissue Engineering |
| HK40075128A | Scalable Bioreactor Systems And Methods For Tissue Engineering |
| HK40004599A | Engineered Skin Equivalent, Method Of Manufacture Thereof And Products Derived Therefrom |
| SG11202200964RA | Scalable Bioreactor Systems And Methods For Tissue Engineering |
| GB2555149B | Engineered Skin Equivalent, Method Of Manufacture Thereof And Products Derived Therefrom |
| ZA202202433A | Scalable Bioreactor Systems And Methods For Tissue Engineering |
| BR112018071667A2 | Genetically Created Skin Equivalent, Method Of Its Manufacturing And Products Derived From It |
| RU2018140838A3 | Engineered Skin Equivalent, Method For Its Production And Products Derived From It |
| IN201817043296A | Engineered Skin Equivalent Method Of Manufacture Thereof And Products Derived Therefrom |
| IL290238A | Scalable Bioreactor Systems And Methods For Tissue Engineering |
| US20190136060A1 | Engineered Skin Equivalent, Method Of Manufacture Thereof And Products Derived Therefrom |
| WO2021021968A1 | Scalable Bioreactor Systems And Methods For Tissue Engineering |
| WO2017184967A1 | Engineered Skin Equivalent, Method Of Manufacture Thereof And Products Derived Therefrom |
| JP2019514423A5 | Engineered Skin Equivalents, Methods Of Making Them And Products Derived Therefrom |
What are VitroLabs‘ key innovation segments?
What Technologies are Covered by VitroLabs?
The chart below distributes patents filed by VitroLabs